A New Study Suggests that Vitamin D Might Slow Prostate Cancer

 New Findings about Vitamin D Concerning Prostate Cancer

MONDAY, March 23, 2015 (HealthDay News) -- Vitamin D supplements may slow or prevent low-grade prostate cancer from progressing, a small new study suggests.

"Vitamin D decreases inflammation in tissues, and inflammation is a driver of cancer," explained Bruce Hollis, the study's lead researcher and a professor of pediatrics, biochemistry and molecular biology at the Medical University of South Carolina in Charleston.

For the study, researchers randomly assigned 37 men who elected to have their prostate removed to receive either 4,000 international units (IU) of vitamin D or an inactive placebo daily for 60 days before their operation.

But it's too early to make blanket recommendation, expert says.

Read more here >>

 Bruce W. Hollis, PhD, Medical University of South Carolina shares the results of a recent trial including identifying the vitamin D level needed to protect the prostate gland.

Learn about "Vitamin D Supplement"

Global Compliance Seminar (GCS) provides global and FDA regulatory consulting and training services to the FDA-regulated industry in collaboration with the Regulatory Doctor. The US FDA is an Agency under the US Department of Health and Human Services (DHHS).